Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;598(7881):473-478.
doi: 10.1038/s41586-021-03974-6. Epub 2021 Oct 13.

Convergent somatic mutations in metabolism genes in chronic liver disease

Stanley W K Ng  1 , Foad J Rouhani  1   2 , Simon F Brunner  1 , Natalia Brzozowska  1 , Sarah J Aitken  3   4   5 , Ming Yang  6 , Federico Abascal  1 , Luiza Moore  1 , Efterpi Nikitopoulou  6 , Lia Chappell  1 , Daniel Leongamornlert  1 , Aleksandra Ivovic  1 , Philip Robinson  1 , Timothy Butler  1 , Mathijs A Sanders  1   7 , Nicholas Williams  1 , Tim H H Coorens  1 , Jon Teague  1 , Keiran Raine  1 , Adam P Butler  1 , Yvette Hooks  1 , Beverley Wilson  1 , Natalie Birtchnell  1 , Huw Naylor  2 , Susan E Davies  4 , Michael R Stratton  1 , Iñigo Martincorena  1 , Raheleh Rahbari  1 , Christian Frezza  6 , Matthew Hoare  8   9 , Peter J Campbell  10   11
Affiliations

Convergent somatic mutations in metabolism genes in chronic liver disease

Stanley W K Ng et al. Nature. 2021 Oct.

Abstract

The progression of chronic liver disease to hepatocellular carcinoma is caused by the acquisition of somatic mutations that affect 20-30 cancer genes1-8. Burdens of somatic mutations are higher and clonal expansions larger in chronic liver disease9-13 than in normal liver13-16, which enables positive selection to shape the genomic landscape9-13. Here we analysed somatic mutations from 1,590 genomes across 34 liver samples, including healthy controls, alcohol-related liver disease and non-alcoholic fatty liver disease. Seven of the 29 patients with liver disease had mutations in FOXO1, the major transcription factor in insulin signalling. These mutations affected a single hotspot within the gene, impairing the insulin-mediated nuclear export of FOXO1. Notably, six of the seven patients with FOXO1S22W hotspot mutations showed convergent evolution, with variants acquired independently by up to nine distinct hepatocyte clones per patient. CIDEB, which regulates lipid droplet metabolism in hepatocytes17-19, and GPAM, which produces storage triacylglycerol from free fatty acids20,21, also had a significant excess of mutations. We again observed frequent convergent evolution: up to fourteen independent clones per patient with CIDEB mutations and up to seven clones per patient with GPAM mutations. Mutations in metabolism genes were distributed across multiple anatomical segments of the liver, increased clone size and were seen in both alcohol-related liver disease and non-alcoholic fatty liver disease, but rarely in hepatocellular carcinoma. Master regulators of metabolic pathways are a frequent target of convergent somatic mutation in alcohol-related and non-alcoholic fatty liver disease.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. The Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169, 1327–1341 (2017). - PMC - DOI
    1. Schulze, K. et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47, 505–511 (2015). - PubMed - PMC - DOI
    1. Totoki, Y. et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat. Genet. 46, 1267–1273 (2014). - PubMed - DOI
    1. Fujimoto, A. et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 44, 760–764 (2012). - PubMed - DOI
    1. Letouzé, E. et al. Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis. Nat. Commun. 8, 1315 (2017). - PubMed - PMC - DOI

Publication types

MeSH terms

LinkOut - more resources